ASTRAZENECA has struck a deal worth up to $400 million with Japan’s Takeda Pharmaceutical to co-develop and commercialise a potential treatment for Parkinson’s disease.
Source: Daily Express :: Finance Feed http://ift.tt/2xx8LaF
Share this
Related Posts
Universal Credit claimants may get Council Tax reductions - check now ahead of 5% hikes
UNIVERSAL Credit claimants can gain access to a range of support on top of their basic payments. This can include add- Mistaken ID victim leads to credit nightmare and long battle to clear his name – Crusader
Will the ghost of mistaken debt markers keep haunting an innocent bank customer or will there be Christmas cheer as t
- Family's Universal Credit axed because of how dad was paid his wages
A FAMILY are struggling to pay for necessities before Christmas after missing out on their monthly Universal Credit p
- Savings warning as Britons ‘woefully unprepared’ for retirement - you may need £250,000
A SAVINGS warning has been issued for Britons approaching their retirement, as many rely on their accounts but do not
EmoticonEmoticon